97,619 Shares in Colgate-Palmolive Company (NYSE:CL) Bought by ASR Vermogensbeheer N.V.

Key Points

• ASR Vermogensbeheer N.V. acquired 97,619 shares of Colgate-Palmolive Company, valued at approximately $9.15 million, during the first quarter.
• Colgate-Palmolive's quarterly earnings exceeded expectations with an EPS of $0.92, compared to a consensus estimate of $0.89, alongside a revenue of $5.11 billion, up 1.0% year-over-year.
• Analysts have varying ratings on Colgate-Palmolive, with recent price targets ranging from $83 to $109, while the stock currently holds an average rating of "Hold" and a consensus target price of $98.92.

ASR Vermogensbeheer N.V. purchased a new position in shares of Colgate-Palmolive Company (NYSE:CL - Free Report) during the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 97,619 shares of the company's stock, valued at approximately $9,147,000.

A number of other large investors also recently modified their holdings of CL. Westend Capital Management LLC grew its stake in Colgate-Palmolive by 111.1% in the first quarter. Westend Capital Management LLC now owns 266 shares of the company's stock valued at $25,000 after purchasing an additional 140 shares in the last quarter. Cornerstone Planning Group LLC boosted its holdings in shares of Colgate-Palmolive by 1,913.3% in the 1st quarter. Cornerstone Planning Group LLC now owns 302 shares of the company's stock valued at $28,000 after buying an additional 287 shares during the last quarter. Vermillion Wealth Management Inc. bought a new position in shares of Colgate-Palmolive in the fourth quarter valued at $31,000. Bernard Wealth Management Corp. acquired a new position in Colgate-Palmolive during the fourth quarter worth $33,000. Finally, Accredited Wealth Management LLC bought a new stake in Colgate-Palmolive during the fourth quarter worth $34,000. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several research firms have recently weighed in on CL. Wells Fargo & Company lowered their price objective on shares of Colgate-Palmolive from $88.00 to $83.00 and set an "underweight" rating on the stock in a research note on Monday. Morgan Stanley set a $96.00 price objective on Colgate-Palmolive and gave the company an "overweight" rating in a research note on Monday. Barclays raised their price objective on Colgate-Palmolive from $86.00 to $87.00 and gave the company an "equal weight" rating in a research report on Tuesday, July 15th. UBS Group decreased their target price on Colgate-Palmolive from $109.00 to $106.00 and set a "buy" rating on the stock in a report on Thursday, July 17th. Finally, Wall Street Zen downgraded Colgate-Palmolive from a "buy" rating to a "hold" rating in a report on Wednesday, May 7th. One analyst has rated the stock with a sell rating, five have given a hold rating and seven have issued a buy rating to the stock. According to data from MarketBeat, the stock currently has an average rating of "Hold" and a consensus target price of $98.92.

Colgate-Palmolive Stock Performance

Shares of NYSE CL opened at $84.58 on Thursday. The company has a debt-to-equity ratio of 6.79, a current ratio of 0.89 and a quick ratio of 0.28. The firm has a market cap of $68.36 billion, a price-to-earnings ratio of 23.76, a P/E/G ratio of 4.32 and a beta of 0.35. The stock's fifty day moving average price is $89.07 and its two-hundred day moving average price is $90.18. Colgate-Palmolive Company has a one year low of $82.40 and a one year high of $109.30.

Colgate-Palmolive (NYSE:CL - Get Free Report) last released its quarterly earnings results on Friday, August 1st. The company reported $0.92 EPS for the quarter, beating the consensus estimate of $0.89 by $0.03. Colgate-Palmolive had a net margin of 14.55% and a return on equity of 377.63%. The business had revenue of $5.11 billion for the quarter, compared to the consensus estimate of $5.03 billion. During the same period in the prior year, the company posted $0.91 earnings per share. Colgate-Palmolive's revenue was up 1.0% compared to the same quarter last year. On average, equities analysts forecast that Colgate-Palmolive Company will post 3.75 EPS for the current year.

Colgate-Palmolive Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, August 15th. Investors of record on Friday, July 18th will be paid a $0.52 dividend. This represents a $2.08 annualized dividend and a dividend yield of 2.5%. The ex-dividend date is Friday, July 18th. Colgate-Palmolive's payout ratio is 58.43%.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.